For the Inventor, By the Inventor

Enter inventor name

White Bear Lake, MN, United States of America

Fatih M Uckun

USPTO Granted Patents = 94 (Patent Applications = 4)

Average Co-Inventor Count = 2.0

ph-index = 20

Forward Citations = 1,362(Granted Patents)

Forward Citations (Not Self Cited) = 1,340(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Minneapolis, MN (US) (1989)
White Bear Leak, MN (US) (2002)
White Bear Lake, MN (US) (1996 - 2023)

Company Filing History:

Parker Hughes Institute

Hughes Institute

University of Minnesota

Wayne Hughes Institute

Ares Pharmaceuticals, LLC

6. 1 out of 1,459

Rutgers, the State University of New Jersey

7. 2 out of 832,966

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2023

Loading Chart...

Areas of Expertise:

Cinchona Alkaloids

HIV Treatment

Vanadium Compounds

Quinazolines

JAK-3 Inhibitors

Cytotoxic Compounds

Transgenic Models

Anti-Angiogenic Agents

Phenoxyethyl Compounds

Spermicidal Activity

Cancer Treatment

Therapeutic Compounds

94 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11649232 - Synthetic dimeric cinchona alkaloids against cancer (2023-05-16),

2. 11066421 - Synthetic cinchona alkaloids against cancer (2021-07-20),

3. 7186736 - NNI for treatment of multi-drug resistant HIV (2007-03-06),

4. 7144874 - Aryl phosphate derivatives of d4T having activity against resistant HIV strains (2006-12-05),

5. 7091351 - Vanadium compounds for treating cancer (2006-08-15),

6. 7038049 - Haloanilino quinazolines and therapeutic use thereof (2006-05-02),

7. 7037937 - Cytotoxic compounds (2006-05-02),

8. 6958359 - Vanadium compounds as anti-angiogenic agents (2005-10-25),

9. 6953875 - Transgenic zebra fish embryo model for hematopoiesis and lymphoproliferative disorders (2005-10-11),

10. 6933300 - JAK-3 inhibitors for treating allergic disorders (2005-08-23),

11. 6878388 - Vanadium compounds for treating proliferative cell disorders (2005-04-12),

12. 6864286 - Inhibitors of the EGF-receptor tyrosine kinase and methods for their use (2005-03-08),

13. 6825177 - Aryl phosphate derivatives of d4T with potent anti-viral activity (2004-11-30),

14. 6800649 - Method for inhibiting c-jun expression using JAK-3 inhibitors (2004-10-05),

15. 6797721 - Phorboxazole derivatives for treating cancer (2004-09-28),

Title: The Innovative Journey of Fatih M. Uckun

Introduction: Fatih M. Uckun is a renowned inventor based in White Bear Lake, MN (US) known for his groundbreaking contributions to the field of medicine and biotechnology.

Latest Patents: Fatih M. Uckun holds several patents in the medical and biotech sectors, focusing on novel treatments for various diseases and innovative medical devices.

Career Highlights: With a distinguished career spanning several decades, Fatih M. Uckun has held key positions in leading research institutions and universities, where he has spearheaded numerous research projects that have led to significant advancements in the medical field.

Collaborations: Throughout his career, Fatih M. Uckun has collaborated with top researchers, scientists, and medical professionals globally, fostering a culture of innovation and excellence in the projects he undertakes.

Conclusion: Fatih M. Uckun's relentless pursuit of innovation and his passion for improving healthcare have solidified his reputation as a pioneering inventor in the medical and biotech industries.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…